Interleukin-21 (recombinant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-21 (recombinant), covering 2009-05-27 to 2009-05-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]